Contractor
LEIDOS BIOMEDICAL RESEARCH INC
- UEI
- HV8BH9BPG8Y9
- Parent UEI
- ZL41ERXMPAR3
- Resolved by
- uei
- Confidence
- 1.000
Active from Sep 24, 2008 to Sep 22, 2026.
Sign in to watchWhat they win
Benchmark categories this contractor appears in, by award count.
| Category | Awards | Obligated |
|---|---|---|
| Facilities Operations Support | 14 | $4,996,664,555 |
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N91019F00134 FFRDC MOONSHOT PORTFOLIO TASK ORDER | Department of Health and Human Services | MD | Aug 30, 2019 | $35,018,135 |
| 75N91021F00013 ENABLING NCI CLINICAL & RESEARCH DATA SHARING | Department of Health and Human Services | MD | Aug 30, 2021 | $98,565,259 |
| 75N91018F00071 HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23 | Department of Health and Human Services | MD | Sep 11, 2018 | $72,263,032 |
| 75N91019F00138 CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS | Department of Health and Human Services | MD | Sep 20, 2019 | $28,263,054 |
| 75N91026F00020 NCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTION | Department of Health and Human Services | MD | Sep 15, 2026 | $4,538,288 |
| 75N91021F00015 CORE SUPPORT FOR THE IMMUNE CELL NETWORK | Department of Health and Human Services | MD | Sep 15, 2021 | $26,946,544 |
| 75N91026F00027 INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES | Department of Health and Human Services | MD | Sep 14, 2026 | $1,088,780 |
| 75N91023F00021 DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS | Department of Health and Human Services | MD | Sep 5, 2023 | $1,649,757 |
| 75N91018F00080 HHSN261201500003I; HHSN26100080; 400.001.0080.0001; NCI OD-FREDERICK; APPROPRIATED; 125073 BLDG. 560, ROOF EXHAUST STACKS; 9/24/2018 - 3/18/2022 | Department of Health and Human Services | MD | Sep 22, 2018 | $9,985,093 |
| 75N91026F00024 IMPLEMENTATION AND CHARACTERIZATION OF IPSC-DERIVED CELL AND ORGANOID MODELS FOR INTEGRATION INTO NEW APPROACH METHODOLOGIES (NAMS) | Department of Health and Human Services | MD | Sep 10, 2026 | $1,323,885 |
| 75N91020F00039 NIAID COVID-19 ACTIV3 | Department of Health and Human Services | MD | Sep 1, 2020 | $159,121,570 |
| 75N91019F00140 HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT | Department of Health and Human Services | MD | Sep 14, 2019 | $9,231,560 |
| 75N91026F00021 126889 B571 REPLACE CHILLER #3 | Department of Health and Human Services | MD | Sep 8, 2026 | $1,291,828 |
| 75N91026F00011 FY26 125346 - B539 STORM DRAIN REPLACEMENT | Department of Health and Human Services | MD | Aug 28, 2026 | $1,064,983 |
| 75N91025F00005 FY26 FFRDC LEASES | Department of Health and Human Services | MD | Aug 28, 2025 | $28,530,382 |
| 75N91026F00031 126297 CAMPUS EVALUATE & REPLACE DEFICIENT ALTERNATING TREAD AND SHIP STAIRS | Department of Health and Human Services | MD | Sep 3, 2026 | $806,968 |
| 75N91026F00028 126797 CAMPUS REPLACE BSCS | Department of Health and Human Services | MD | Sep 3, 2026 | $1,912,753 |
| 75N91019F00139 MD NET | Department of Health and Human Services | MD | Sep 26, 2019 | $181,379,395 |
| 75N91021F00001 CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) | Department of Health and Human Services | MD | Feb 10, 2021 | $79,896,408 |
| 75N91024F00021 NIAID VRC PRE-CLINICAL ASSESSMENT | Department of Health and Human Services | MD | Jun 17, 2024 | $16,097,583 |
| 75N91025F00016 NCI OPERATIONAL TASK ORDER, FY26-FY27 | Department of Health and Human Services | MD | Aug 29, 2025 | $839,397,868 |
| 75N91026F00017 126729 ROOM 524 D, E, F | Department of Health and Human Services | MD | Aug 28, 2026 | $1,102,374 |
| 75N91025F00014 NIAID VRC FY26-27 OPERATIONAL TASK ORDER | Department of Health and Human Services | MD | Aug 27, 2025 | $87,806,507 |
| 75N91026F00030 126869 B539 & 560 - ROOF REPLACEMENTS | Department of Health and Human Services | MD | Aug 27, 2026 | $1,511,990 |
| 75N91026F00023 FFRDC DRUG PRODUCT FORMULATION, MANUFACTURE, AND STABILITY STUDIES OF BETHANECHOL CHLORIDE FOR PHASE I CLINICAL TRIALS | Department of Health and Human Services | MD | Aug 26, 2026 | $1,644,574 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier HV8BH9BPG8Y9, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 24, 2026.